BBIO fund manager activity
BridgeBio Pharma, Inc · Nasdaq. Reported by 6 tracked fund managers in their 13F filings, Q2 2019 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ken Fisher - Fisher Asset Management | New | 232,401 | $17,776,351 | 0.01% | Feb 9, 2026 |
| Polen Capital Management | Added | 38,241 | $2,925,054 | 0.01% | Feb 12, 2026 |
| Viking Global Investors | Trimmed | 14,393,934 | $1,100,992,012 | 2.92% | Feb 17, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Polen Capital Management | Added | 36,164 | $1,878,358 | 0.01% | Nov 12, 2025 |
| Viking Global Investors | Trimmed | 15,977,849 | $829,889,477 | 2.16% | Nov 14, 2025 |